Bharat Biotech's Covaxin approved by Hong Kong
Covid-19: Hong Kong has given approval to Bharat Biotech's Covaxin for international passengers.
Earlier on November 9, the United Kingdom had said it would be adding Covaxin to the list of approved Covid-19 vaccines, beginning November 22. Now, those inoculated with the Bharat Biotech-manufactured vaccine will not have to self-isolate after arrival in England.
On November 3, the World Health Organisation (WHO) had granted emergency use approval for Covaxin.
Also read | Punjab: Bathinda Rural AAP MLA Rupinder Kaur Ruby quits party
The Central Drugs Standard Control Organisation (CDSCO) has also approved the extension of the shelf life of Covaxin up to 12 months from the date of manufacture.
In total, Hong Kong has approved 14 vaccines, including Covaxin. Union Health Minister Mansukh Mandaviya had said Covid-19 vaccines — Covaxin and Covishield — had been recognised by as many as 96 countries.
Also read | Rajasthan: Many feared dead as bus catches fire after colliding with tanker; see video
It is learnt that Bharat Biotech's partner in the US and Canada has submitted a request to the US Food and Drug Administration (FDA) for emergency use authorisation (EUA) of Covaxin for paediatric use.
